- About us
- Company details
Vision Engineering Italy s.r.l. (www.visioeng.com) is a SME settled in Rome, Italy. The mission of Vision Engineering Italy is to meet the medical needs through inventive and smart technological solutions.
The company focuses on the development of high-tech medical devices for the treatment of corneal diseases. The firm has created the new paradigm, VET-CXL, for treating ocular infections in veterinary medicine with unprecedent efficacy. Vet-cxl takes 15 minutes and is performed using our proprietary product portfolio, including a point-of-care UV-A device, VETUVIR, and a photo-active ophthalmic solution, EQUIRVIS. A multicenter randomized controlled clinical trial has determined that our innovative proprietary product is 84% superior to topical antimicrobials for treating infections.
Year of establishment:
2014
Number of employees:
0
Annual turnover:
Under 250.000 Euro
Reference year of turnover:
2018
Export turnover:
0
Activities:
Manufacture of irradiation, electromedical and electrotherapeutic equipment
Manufacture of medical irradiation, electromedical and electrotherapeutic equipment
Manufacture of medical and dental supplies
Research and experimental development on biotechnology
Other research and experimental development on natural sciences and engineering nec
- Videos
- Catalogue
No videos uploaded
No documents uploaded
- Contact Information
- Business Proposals
Company:
VISION ENGINEERING ITALY SOCIETA' A RESPONSABILITA' LIMITATA
Telephone:
+393313438300
Web site:
Address:
VIA LIVENZA 3
City:
ROMA (RM)
Zip Code:
00198
E-commerce:
Social media:
Tag:
No business proposals uploaded
- Map
Vetuvir
Vetuvir is a point-of-care UV-A device for treating corneal infections in companion animals and horses. For veterinary practioners only. The device has shown - in multicenter controlled clinical trial, to be superior to topical antimicrobial therapy for the treatment of septic corneal ulcers in companion animals and horses. The device has been manufactured according to Dir. CEE 2001/95, 2006/42/CEE and 2014/30/UE.
Web site
http://www.vetuvir.com
Documents
Equirvis
Equirvis is a high-concentration riboflavin ophthalmic solution for exclusive use in vetrinary medicine. It has been specifically formulated for VET-CXL, allowing quick passage of the riboflavin into the corneal stroma for the most efficient treatment of septic corneal ulcers using VETUVIR.
Web site
http://www.vetuvir.com
Documents